- Home
- LENZ vs OMI Comparison
LENZ vs OMI Comparison
Compare LENZ & OMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LENZ
- OMI
- Stock Information
- Founded
- LENZ 2019
- OMI 1882
- Country
- LENZ United States
- OMI United States
- Employees
- LENZ N/A
- OMI N/A
- Industry
- LENZ Medicinal Chemicals and Botanical Products
- OMI Medical Specialities
- Sector
- LENZ Health Care
- OMI Health Care
- Exchange
- LENZ Nasdaq
- OMI Nasdaq
- Market Cap
- LENZ 886.2M
- OMI 909.7M
- IPO Year
- LENZ 2021
- OMI N/A
- Fundamental
- Price
- LENZ $34.32
- OMI $12.24
- Analyst Decision
- LENZ Strong Buy
- OMI Buy
- Analyst Count
- LENZ 6
- OMI 6
- Target Price
- LENZ $35.40
- OMI $19.58
- AVG Volume (30 Days)
- LENZ 157.8K
- OMI 818.3K
- Earning Date
- LENZ 11-06-2024
- OMI 11-04-2024
- Dividend Yield
- LENZ N/A
- OMI N/A
- EPS Growth
- LENZ N/A
- OMI N/A
- EPS
- LENZ N/A
- OMI N/A
- Revenue
- LENZ N/A
- OMI $10,660,960,000.00
- Revenue This Year
- LENZ N/A
- OMI $4.87
- Revenue Next Year
- LENZ N/A
- OMI $4.01
- P/E Ratio
- LENZ N/A
- OMI N/A
- Revenue Growth
- LENZ N/A
- OMI 4.22
- 52 Week Low
- LENZ $2.12
- OMI $11.42
- 52 Week High
- LENZ $38.93
- OMI $28.35
- Technical
- Relative Strength Index (RSI)
- LENZ 62.24
- OMI 43.06
- Support Level
- LENZ $31.59
- OMI $11.79
- Resistance Level
- LENZ $35.40
- OMI $12.58
- Average True Range (ATR)
- LENZ 2.74
- OMI 0.68
- MACD
- LENZ -0.08
- OMI -0.01
- Stochastic Oscillator
- LENZ 60.16
- OMI 35.13
About LENZ LENZ Therapeutics Inc. Common Stock
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing innovative therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.
About OMI Owens & Minor Inc.
Owens & Minor Inc distributes consumable medical supplies to a variety of providers. The business is under two segments: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment manufactures and sources medical surgical products through its production and kitting operations and provides medical supplies and solutions for the prevention of healthcare-associated infections across the acute and alternate site channels. The Patient Direct segment provides delivery of disposable medical supplies sold directly to patients and home health agencies. Majority of the revenue is generated from Products & Healthcare Services segment.